Acadia Pharmaceuticals | Ventes



Sales Changement Date
Acadia Pharmaceuticals USD 259.6M 9.2M 2024-12
ALKERMES USD 306.5M 123.5M 2025-03
Alnylam Pharmaceuticals USD 594.19M 1.02M 2025-03
Biogen USD 2.43B 24.7M 2025-03
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
Corcept Therapeutics USD 157.2M 24.69M 2025-03
Cytokinetics USD 1.6M 15.33M 2025-03
Eisai JPY 216.14B 20.15B 2024-12
Eli Lilly USD 12.73B 802.8M 2025-03
Incyte USD 1.05B 128.7M 2025-03
J&J USD 21.89B 630M 2025-03
Moderna USD 108M 858M 2025-03
Neurocrine Biosciences USD 572.6M 55.1M 2025-03
Pfizer USD 13.72B 4.04B 2025-03
Prothena USD 2.12M 1.15M 2024-12
PTC Therapeutics USD 190M 23.17M 2025-03
Sarepta Therapeutics USD 774.9M 116.49M 2025-03
Ultragenyx Pharmaceutical USD 164.88M 25.38M 2024-12
Vertex Pharmaceuticals USD 2.77B 142M 2025-03



Acadia Pharmaceuticals Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.